Huang Li-Ping, Zhang Leng, Wang Xing-Lin, Liu Xiao-Cui, Jiang Tian-Yu, Lin Bi-Weng
Department of Physical Therapy, Chinese PLA General Hospital, Beijing 100853, China.
Int J Ophthalmol. 2012;5(2):181-5. doi: 10.3980/j.issn.2222-3959.2012.02.13. Epub 2012 Apr 18.
To evaluate the efficacy of intralesional radiofrequency ablation in the treatment of periorbital syringomas.
We tried the intralesional radiofrequency ablation for 64 patients with periorbital syringomas from 2007 to 2011. The operation was performed under 2.5 loupe magnifications. The handpiece was assembled with a needle electrode and connected to the radiofrequency ablation apparatus. The electrode was then inserted into the target lesions in dermis and delivering injury to the base of these tumors. Results were assessed clinically by comparing pre- and post-treatment photographs and patient satisfaction rates.
Clinical improvement increased with each subsequent treatment session. The percent of patients whose clinic improvement grade were≥3 after each session was respectively 71.9%(Session1), 83.3%(Session2), and 100%(Session3). The statistical results indicated the concordance of the clinical assessment and the satisfaction level of patients (kappa=0.78 of the session1; kappa=0.82 of the session2). The majority of patients had good or excellent cosmetic results. Postoperatively, there were no permanent side effects or recurrences.
As a new technique of minimally invasion, the intralesional radiofrequency ablation was found to be an effective, inexpensive, highly precise and safe way of treating periorbital syringomas.
评估病灶内射频消融术治疗眶周汗管瘤的疗效。
2007年至2011年，我们对64例眶周汗管瘤患者尝试采用病灶内射频消融术。手术在2.5倍放大镜放大下进行。将手持器械与针状电极组装在一起，并连接到射频消融设备上。然后将电极插入真皮层的目标病变中，对这些肿瘤的基底造成损伤。通过比较治疗前后的照片和患者满意度来进行临床评估。
每次后续治疗后临床改善情况均有所增加。每次治疗后临床改善等级≥3级的患者百分比分别为71.9%（第1次治疗）、83.3%（第2次治疗）和100%（第3次治疗）。统计结果表明临床评估与患者满意度水平具有一致性（第1次治疗kappa=0.78；第2次治疗kappa=0.82）。大多数患者获得了良好或极佳的美容效果。术后无永久性副作用或复发情况。
作为一种新的微创技术，病灶内射频消融术是治疗眶周汗管瘤的一种有效、廉价、高精度且安全的方法。
